Trial Profile
A controlled phase 2 trial assessing three doses of T-20 [enfuvirtide] in combination with abacavir, amprenavir, ritonavir, and efavirenz in HIV-1 infected adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2005
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Abacavir; Amprenavir; Efavirenz
- Indications HIV-1 infections
- Focus Therapeutic Use
- 21 Oct 2005 New trial record.